Shuttle Pharmaceuticals Holdings (SHPH) Net Cash Flow (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Net Cash Flow history runs 6 years deep, the most recent figure standing at $755941.0 for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 70.84% year-over-year to $755941.0 in Q1 2026; TTM through Mar 2026 was -$365939.0, a 111.75% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, down 141.69% from the prior year.
• Net Cash Flow retreated to $755941.0 in Q1 2026 per SHPH's latest filing, from $1.3 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $9.1 million in Q3 2022 and bottomed at -$2.7 million in Q3 2025.
• The 5-year median for Net Cash Flow is -$538938.0 (2024), against an average of $214230.5.
• Across the five-year window, Net Cash Flow tumbled 1161.92% in 2023 and soared 320.11% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$703187.0 in 2022, then tumbled by 86.24% to -$1.3 million in 2023, then surged by 234.66% to $1.8 million in 2024, then decreased by 26.5% to $1.3 million in 2025, then plunged by 41.67% to $755941.0 in 2026.
• Per Business Quant, the three latest SHPH Net Cash Flow figures stand at $755941.0 (Q1 2026), $1.3 million (Q4 2025), and -$2.7 million (Q3 2025).